Anthracyclines are antitumor agents whose main clinical limitation is cardiac toxicity. The mechanism of this cardiotoxicity is thought to be related to generation of oxidative stress, causing lethal injury to cardiac myocytes. Although protein and lipid oxidation have been documented in anthracycline-treated cardiac myocytes, DNA damage has not been directly demonstrated. This study was undertaken to determine whether anthracyclines induce cardiac myocyte DNA damage, and whether this damage is linked to a signaling pathway culminating in cell death. H9C2 cardiac myocytes were treated with the anthracycline doxorubicin at clinically relevant concentrations, and DNA damage was assessed utilizing the alkaline comet assay. Doxorubicin induced DNA 
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isolated myocytes subjected to oxidatant injury, including ischemia-reperfusion (38) and antioxidant depletion (11) , indicating that this cell type is susceptible to oxidant-induced DNA damage. In addition to oxidative DNA damage, anthracyclines bind avidly to DNA in the nucleus of cancer cells, forming adducts that can interfere with binding of proteins such as transcription factors and RNA polymerase, potentially interfering with the important cellular functions of DNA, including replication and transcription (7) .
DNA damage in proliferative cells activates a pathway that arrests cell division to allow either DNA repair or the induction of cell death by apoptosis. p53 is an effector protein in this pathway that plays a critical role in the induction of cell cycle arrest and apoptosis (39) . Once activated, p53 translocates to the nucleus, where it induces expression of genes that prevent cell division (i.e. p21), and cause apoptosis (e.g. Bax) (6) . In more differentiated skeletal muscle cells, DNA lesions induced by AC exposure also induce apoptosis in a p53-dependent fashion (19). An alternate response by cells subjected to DNA damage is lesion repair rather than apoptosis. DNA repair utilizes enzymes that excise oxidized bases before DNA replication (3), remove oxidized bases from the nucleotide pool (8) , or remove oxidized bases from DNA after replication (33). Since cardiac myocytes are post-replicative, repair of DNA lesions is important to avoid deterioration of cardiac function that would eventually attend myocyte loss.
Indeed, nucleotide excision repair, particularly of the transcribed strand, is very 7
Materials and Methods

Cell Culture and Treatment
The H9C2 cardiac cell line was derived from embryonic rat heart by selective serial passage (15) . Cells were plated on 35 or 100 mm dishes in DMEM with 10% fetal calf serum and utilized when 70-90% confluent. The AC doxorubicin (DOX) was added to complete medium and incubated at 37 o C for various intervals at a concentration (0.5 µg/ml) similar to plasma concentrations encountered in clinical use (10) . In some experiments, the free radical scavenger amifostine was included during DOX treatment at a concentration of 14 mM (4).
Alternatively, a chemical inhibitor of p53, pifithrin (16) Oxidative stress, radiation, and AC cause DNA damage that can be detected and quantified using the alkaline comet assay (31), (4) . During electrophoresis, undamaged DNA is largely confined to the nucleus, while damaged DNA 8 migrates apart from the nucleus in the shape of a comet. The length and fluorescent intensity of the comet are proportional to the number of DNA strand breaks. The extent of DNA damage can be quantified by the use of this sensitive technique, with the most frequently reported measure being the tail moment, a product of tail length and percent tail DNA (34). We performed the assay essentially as described by Singh et al (31) .
Evaluation of DNA Damage
After electrophoresis, DNA was stained with 1% propidium iodide, slides were coverslipped, and analyzed by fluorescent microscopy using an excitation filter of 515-560 nm and a barrier filter of 590 nM. An image analysis system (Kinetic Imaging, Bromborough, Wirral, U.K.) was used to measure indices of DNA damage. Digitized images were obtained of 50 randomly selected cells per slide and the tail moment was determined from 2 slides per condition. The median tail moment was determined for each slide, and the mean of at least 8 of these values per condition (i.e. at least 2 slides per condition from at least 4 separate days) was used as the index of DNA damage. The tail moment was expressed as fold elevation above a negative control slide from the same day to account for daily variability in cell health. Addition of repair enzymes to the comet assay allows identification of specific lesions in DNA induced by DOX (5). DOX-treated lysed cells were washed 3 times in buffer supplied with each enzyme, drained, and covered with 25 µl of either enzyme buffer or buffer with 0.01 unit enzyme per µl, sealed with a cover slip, and incubated for 30 min at 37 o C. Cells were subjected to electrophoresis and scoring of DNA damage as described above.
Trypan Blue Exclusion
Trypan blue is a vital dye excluded by viable cells with intact cell membranes, while nonviable cells fail to exclude the dye. After treatment with DOX, floating and attached cells were collected by gentle trypsinization followed by neutralization with serum-containing medium. Subsequently, a small volume of 0.4% trypan blue was added to cells collected from each dish, and the number of cells excluding or staining with the dye was immediately counted on a Nikon microscope as described (18) To determine whether DNA damage induced by DOX could be repaired, cells were treated with 0.5 µg/ml DOX for 4 hours and allowed to repair DNA damage in fresh medium at 37 o C for varying intervals before performing the comet assay.
As shown in fig. 4 Moreover, antioxidants are not cardiac specific, but rather reduce oxidative stress nonspecifically. This potentially reduces the desired effect of AC since oxidative stress plays a role in the tumor-killing effect of these agents (14) . Knowing that DNA injury occurs in myocytes treated with DOX and that elements of the DNA damage pathway are subsequently activated identifies additional steps that can be inhibited to reduce AC-induced cardiac myocyte death. Inhibition of p53 specifically in the heart, for example, may be a treatment to pursue, and this approach has been validated in animal studies (21). The observation that is lost after p53 activation in cardiac myocytes provides an additional target, since cyclosporine, diazoxide, and pinacidil prevent loss in response to cardiac myocyte oxidative stress (1) . Agents that specifically act on cardiac myocyte mitochondria to preserve offer the potential to block the detrimental effects of AC while preserving anti-tumor activity, and such agents are currently under investigation (13) . 
